DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix. - Chae YK; Othus M; Patel SP; Backes FJ; O'Malley DM; Cristea M; Naing A; Kurnit K; Eskander RN; T Goodrich S; Robinson WR; Scalici J; et al. (Journal for immunotherapy of cancer, 2026)